Is this strain worth developing as a bio-input?
Develop as a biocontrol and biostimulant agent, paired with a nitrogen-fixing partner
- Outperforms the benchmark in induced resistance, siderophores, lytic enzymes and antifungal clusters.
- No virulence factors or mobile resistance genes: suitable for a registration dossier.
- Closest ANI 93.1%: a putative new species, which strengthens intellectual property.
- Gaps in nitrogen fixation and motility are covered by a partner strain and seed-coating formulation.
Functional fingerprint vs. 20 reference strains
Linear discriminant analysis on 276 genomic categories (PCA-imputed gene frequencies). Ellipses show 68% confidence regions per reference group.
Genomic partitions
Z-score of each functional category in GC-01 relative to the benchmark set.
Biosynthetic gene clusters
antiSMASH regions ranked by agronomic interest. Metabolites marked as confirmed were detected by LC-MS/MS in culture extracts.
| Region | Type | Most similar known cluster | Similarity | Predicted role | LC-MS/MS | Priority |
|---|
10 of 29 regions shown. Clusters with low similarity to known compounds are flagged as candidates for new molecules.
Pest and pathogen control potential
Genomic potential score (0–100) from antifungal clusters, lytic enzymes, siderophores and induced-resistance genes. Select a target to read the evidence.
How to read it
Scores prioritize which pathogens to test first in dual culture and greenhouse assays. They are not efficacy claims.
Biosafety screen
Overall: greenConsortium fit
Partners that cover GC-01's gaps, with predicted compatibility and the test that confirms it.
| Gap in GC-01 | Suggested partner | Crop | Compatibility | Confirm with |
|---|
Files delivered
GC-01_executive_summary.pdf2 pages, for managementGC-01_profile.htmlthis interactive reportGC-01_technical_report.pdfmethods, QC, figures, referencesGC-01.fasta · .gbk · .gff3closed assembly and annotationantiSMASH/ · CARD/ · VFDB/full tool outputsfingerprint_matrix.csv · lda_scores.csv276 categories × 21 strainsraw/*.fastq.gz + md5Illumina + Nanopore readscode/ (R: MASS, missMDA, ggplot2)reproducible analysis
Next lab steps planned in the report
- Dual-culture assays against Fusarium, Macrophomina and Sclerotinia isolates.
- Co-culture compatibility with the selected Bradyrhizobium partner.
- Greenhouse trial: growth promotion and disease index, 4 treatments × 6 replicates.
- Formulation (spores on carrier) and shelf-life at 3 and 6 months.
- Field trial design with randomized blocks and yield as the primary endpoint.